Mitochondrial dysfunction and risk of cancer

Area of Science:

• Mitochondrial biology
• Oncology
• Genetics

Background:

• Mitochondrial mutations are frequent in tumors, raising questions about their role in cancer development.
• The causal relationship between impaired mitochondrial function and cancer remains unclear.

Purpose of the Study:

• To investigate the cancer risk associated with mitochondrial dysfunction.
• To determine if impaired mitochondrial function is a cause or consequence of cancer.

Main Methods:

• A nationwide cohort of 311 patients with mitochondrial dysfunction was established using genetic testing data and the Danish Civil Registration System.
• Cancer incidence was tracked via the Danish Cancer Register, with standardized incidence ratios (SIRs) used to calculate relative risk.

Main Results:

• Over 7334 person-years, 19 subjects developed cancer, resulting in a standardized incidence ratio (SIR) of 1.06 for any primary cancer (95% CI 0.68-1.63).
• Subgroup analyses, including for the m.3243A>G mutation, showed no increased cancer risk.

Conclusions:

• Individuals with mitochondrial dysfunction do not exhibit an elevated risk of cancer compared to the general population.
• The findings suggest mitochondrial dysfunction is likely a consequence, not a cause, of cancer.